El consejero de sanidad, Javier Fernández Lasquetty, presentó, el pasado lunes, los primeros resultados de cinco de los 29 programas específicos orientados a personas mayores que el hospital de La Princesa está desarrollando, y que hasta el momento han beneficiado a cerca de 500 pacientes. Los 24 planes restantes también han comenzado, y están cada uno de ellos, en una fase diferente de desarrollo.
The current treatment preference for intracranial atherosclerotic disease is not intervention but medical management with neurosurgeons reluctant to request stenting by the interventionalist since the SAMMPRIS trial, according to a company release.
Stent-assisted coiling has evolved as an aneurysm treatment option for patients with large, side-wall or wide-neck aneurysms. Although stent-assisted coiling has been associated with lower angiographic recurrence rates than coiling alone for anatomically challenging aneurysms, high complications rates have been published. One study reported permanent neurological complications in 7.4% and procedure related mortality in 4.6% of patients, which was significantly higher than for those treated with coiling alone.(1) An editorial following this study commented on an “alarmingly high serious complication rate of stent-assisted coiling” in this cohort of largely unruptured aneurysms with a benign natural history.(2)
At the Carotid Challenge session, which took place at CX35 today in the main auditorium, 62% of delegates said that they believed flow diversion was a “game changer” after Andrew Platts, London, UK, spoke to them about the intervention for the anterior cerebral circulation.
In Leicester, UK, rapid-access surgery for symptomatic carotid stenosis has been offered since October 2008. Ross Naylor reviews the practical lessons that have been learned with the experience. He discussed this topic at CX35 on Tuesday.
En pacientes con fibrilación auricular (FA) "del mundo real", los resultados a largo plazo son superiores con dabigatrán (Pradaxa) que con warfarina, a pesar de tener la misma frecuencia de accidentes cerebrovasculares (ACV), embolias sistémicas y sangrados graves, revela un estudio realizado en Dinamarca tras la aprobación del fármaco.
The findings of study led by Jai J Shakar and published in Journal of NeuroInterventional Surgery indicated that the rupture of posterior communicating artery aneurysms, where clots obscure the aneurysm neck in the immediate post-coiling period (≤3days), is rare but has a 70% mortality rate.
Comer más alimentos ricos en fibra aparentemente reduce el riesgo de accidente cerebrovascular (ACV), según un nuevo estudio británico.
A stroke survivor s chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according to a randomized controlled trial involving 656 patients.
InspireMD is the developer of the MGuard Embolic Protection Stent and announced on 15 March 2013 that the company received CE mark approval for its self-expanding Nitinol carotid Embolic Protection Stent. This carotid embolic protection stent is based on the proprietary MicroNetmesh protection platform technology used to treat myocardial infarction patients with InspireMD’s commercially available coronary Embolic Protection Stent stents, MGuard and MGuard Prime.
Si se sospecha de trauma encefálico, los profesionales de la atención de la salud deben determinar si es seguro volver a jugar, según las recomendaciones
Pero un estudio japonés de gran tamaño no demostró que hubiera una relación de causa y efecto
Un estudio de caso describe a un hombre cuyo único síntoma claro era no darse cuenta de que sus mensajes eran disparatados
In patients undergoing carotid artery stenting, a strategy using both a 600mg clopidogrel load and a short-term reload with high-dose atorvastatin protects against early ischaemic cerebral events, according to a study presented at the American College of Cardiology Scientific Session (9–11 March 2013, San Francisco, USA).
InspireMD is the developer of the MGuard Embolic Protection Stent and announced on 15 March 2013 that the company received CE mark approval for its self-expanding Nitinol carotid Embolic Protection Stent. This carotid embolic protection stent is based on the proprietary MicroNetmesh protection platform technology used to treat myocardial infarction patients with InspireMD’s commercially available coronary Embolic Protection Stent stents, MGuard and MGuard Prime.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos